Following the announcement of GST rate cuts from Union Finance Minister Nirmala Sitharaman in the 54th GST council meeting, shares of pharmaceutical companies specialising in cancer drugs experienced a surge, with some seeing an increase of up to 4 per cent. This uptick coincided with a surge in benchmark indices. The GST meeting announcement said that the Goods and Services Tax (GST) on cancer drugs would be reduced from 12 per cent to 5 per cent. This decision was aimed at lowering the overall cost of cancer treatment.